Issue · Healthcare

Healthcare (Prescription Drugs)

Every healthcare bill, vote, and legislator stance in Missouri, automatically classified by Maddy, our AI policy reader.

Total bills
35
2026 Regular Session
Top supporter
Aaron Crossley
100% support rate
Top opponent
Bill Hardwick
0% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving prescription drugs in Missouri

Legislators moving prescription drugs in Missouri
Legislator Party Stance Support rate Decisive votes
Aaron Crossley
Aaron Crossley House · District 29
D
Strong +
100% 4
Adrian Plank
Adrian Plank House · District 47
D
Strong +
100% 4
Ashley Aune
Ashley Aune House · District 14
D
Strong +
100% 4
Betsy Fogle
Betsy Fogle House · District 135
D
Strong +
100% 4
Bill Allen
Bill Allen House · District 17
R
Strong +
100% 4
Bill Hardwick
Bill Hardwick House · District 121
R
Strong −
0% 4
Bob Titus
Bob Titus House · District 139
R
Strong −
0% 4
Burt Whaley
Burt Whaley House · District 138
R
Strong −
0% 4
Jeff Coleman
Jeff Coleman House · District 32
R
Strong −
0% 4
John Simmons
John Simmons House · District 109
R
Strong −
0% 4
Showing 11–20 of 35 bills

All healthcare bills

in committee · Missouri · House May 15, 2026

HB 2757: Modifies provisions relating to access to medical products

HB 2757 expands pharmacists' scope of practice in Missouri by allowing licensed pharmacists with special certification to develop medication therapy management plans under written protocols from physicians. It permits pharmacists to administer certain vaccines (excluding cholera, monkeypox, and others) and provide HIV post-exposure prophylaxis, all while requiring adherence to CDC guidelines and physician protocols. This directly affects pharmacists (who must complete additional training), physicians collaborating with them, and patients receiving these expanded services. The bill explicitly prohibits pharmacists from independently diagnosing or prescribing, except for emergency insulin supplies under existing law. It also establishes joint rules for vaccine administration and medication therapy protocols between pharmacy and medical boards.
in committee · Missouri · House May 15, 2026

HB 2726: Creates provisions relating to insurance coverage of drugs

HB 2726 requires Missouri health insurance plans (effective January 1, 2027) to cover a prescribed drug without forcing patients to switch to an alternative drug, unless a patient's doctor provides written approval stating the switch is medically necessary. This directly affects patients prescribed specific medications and health insurers offering plans in Missouri. The bill prevents insurers from mandating drug substitutions solely for cost reasons, ensuring coverage for the doctor-recommended drug. Exceptions include existing step therapy protocols and interchangeable biological products, as specified in related laws.
passed · Missouri · House Mar 31, 2026

HB 2642: Creates provisions relating to insurance coverage of alternatives to opioid drugs

HB 2642 requires health insurance plans to cover nonopioid medications for acute pain without barriers, directly affecting people with health insurance (enrollees) and the plans themselves. The law prohibits plans from denying coverage for nonopioid drugs in favor of opioids, forcing patients to try opioids first, or charging higher costs for nonopioid options compared to opioids. It applies only to acute pain (expected to last 30 days or less) and takes effect for plans renewed or issued after January 1, 2027. The bill does not change provider prescribing practices but mandates equal treatment for nonopioid alternatives under insurance coverage.
passed · Missouri · House May 5, 2026

HB 3009: Creates provisions relating to pharmacies

HB 3009 allows Missouri's Board of Pharmacy to temporarily waive certain state rules for nonprofit pharmacies (501(c)(3) organizations licensed in Missouri) during declared disasters. These pharmacies can then ship prescription drugs to affected areas without following standard state regulations, provided they are responding to an active emergency and comply with federal rules and local disaster guidelines. The waiver applies only during the official disaster period (60 days after a governor's or federal emergency declaration) and is limited to the geographic area specified in the emergency declaration. It does not change routine pharmacy operations outside of emergencies.
Sub-Topics Prescription Drugs Tags Emergency Management
in committee · Missouri · House May 15, 2026

HB 3008: Modifies provisions relating to the practice of pharmacy

HB 3008 expands pharmacists' scope of practice to include managing medication treatment plans under physician protocols for specific conditions like minor illnesses, emergencies, or chronic conditions without requiring a new diagnosis. It permits pharmacists to prescribe nicotine replacement therapy, administer certain vaccines (excluding specific high-risk types), and provide HIV postexposure prophylaxis, all while working within defined boundaries. The bill requires written protocols from physicians (not nurses or physician assistants) and explicitly prohibits pharmacists from diagnosing or independently prescribing outside these specified scenarios. It also clarifies that pharmacists remain responsible for supervising support staff and maintains existing regulations for pharmacy ownership and nonprescription drug sales.
vetoed · Missouri · House Jun 30, 2026

HB 2005: Appropriates money for the expenses, grants, refunds, and distributions of the Office of Administration, the Department of Transportation, the Department of Conservation, the Department of Public Safety, and the Chief Executive's Office

HB 2005 is Missouri's fiscal year 2026-2027 state budget bill, allocating $3.33 million from the General Revenue Fund to fund specific state operations and programs for the 2026-2027 fiscal year. It directly provides funding for the Office of Administration's Commissioner's Office ($1.28M), the Office of Equal Opportunity ($481K), the Prescription Drug Monitoring Program ($1.47M), and the America 250 Missouri Commission ($100K). The bill also allocates $18.08 million for the Office of Administration's IT division, including $62.45 million from a dedicated technology trust fund for statewide IT systems and infrastructure. This is a routine funding measure that authorizes state departments to spend designated amounts for their operations and specific programs, with minor flexibility provisions allowing limited reallocation between budget categories.
in committee · Missouri · House May 15, 2026

HB 3117: Enacts provisions relating to insurance coverage for prescription insulin drugs

HB 3117 requires health insurance plans in the state to cap out-of-pocket costs for prescription insulin at $30 per 30-day supply for people with diabetes. It mandates that plans reduce the drug price by 100% of all rebates received (before applying cost-sharing), ensuring the $30 limit reflects the lowest possible price. The bill protects rebate information as trade secrets, preventing health plans from disclosing rebate details to the public or third parties. This law applies to all health benefit plans issued, renewed, or continued on or after January 1, 2027.
in committee · Missouri · House Mar 12, 2026

HB 1975: Modifies provisions relating to pharmacy benefits managers

HB 1975 revises Missouri's laws governing pharmacy benefits managers (PBMs) to protect patient choice and ensure fair reimbursement for pharmacies. The bill prohibits PBMs from penalizing patients for choosing non-network pharmacies (e.g., via higher co-pays) or requiring pharmacies to meet extra certification standards beyond state licensing rules. It also mandates that PBMs reimburse pharmacies at least the National Average Drug Acquisition Cost (NADAC) for prescription drugs. These changes directly affect patients, pharmacies, and PBMs by ensuring transparent pricing and preserving patient freedom to select their pharmacy.
Sub-Topics Prescription Drugs
in committee · Missouri · House Feb 12, 2026

HB 2279: Creates provisions relating to cost-sharing under health benefit plans

HB 2279 requires Missouri health benefit plans to include costs for non-generic medications in an enrollee's out-of-pocket maximum. This means if a generic drug isn't available for a prescribed medication, the full cost paid by the enrollee (or on their behalf) counts toward their annual limit on out-of-pocket expenses. The bill also prohibits plans from adjusting cost-sharing requirements based on whether a patient qualifies for drug cost assistance programs. It applies to most health plans (excluding certain union plans) starting August 28, 2026, and affects all Missouri residents enrolled in health insurance plans covering prescription drugs.
in committee · Missouri · House May 15, 2026

HB 1976: Modifies provisions relating to the ordering and administration of vaccines by pharmacists

HB 1976 updates Missouri law to allow pharmacists to order and administer most vaccines approved by the U.S. Food and Drug Administration, excluding specific vaccines like cholera, monkeypox, and those jointly excluded by state boards after January 1, 2023. It directly affects pharmacists and patients aged seven or older (or the age recommended by the CDC for a vaccine), expanding pharmacists' role in vaccine administration. Key provisions require joint rulemaking by the pharmacy board and the healing arts board to define covered vaccines, while maintaining existing restrictions on certain diseases and emergency protocols. The bill removes prior limitations on pharmacist vaccine authority, making it a concrete policy change to increase vaccine access through pharmacies.
Sub-Topics Prescription Drugs
Showing 11 to 20 of 35 bills
Previous 1 2 3 … 4 Next